Skip to content

Supplier News

Perrigo releases generic of Luxiq Foam

Perrigo Co. has begun shipping betamethasone valerate foam 0.12%, a treatment for psoriasis. The company said Tuesday that the product, released according to the date certain launch settlement previously announced, is the generic equivalent of Stiefel’s Luxiq Foam. Cobrek Pharmaceuticals Inc.

Pfizer ships ADHD drug

Pfizer Inc. has released Quillivant XR, an extended-release liquid medication for attention deficit hyperactivity disorder (ADHD), to U.S. pharmacies.

Kardashian beauty line to hit shelves at Duane Reade

Duane Reade is slated to carry the Khroma Beauty by Kourtney Kim and Khloe (Kardashian) collection from Boldface Group Inc. The beauty product marketer and licenser said Thursday that plans call for the product line to hit shelves at 138 Duane Reade stores this spring.

Macy’s CEO joins P&G board

Terry Lundgren, chairman, president and chief executive officer of Macy’s Inc., has been named to the board of directors of Procter & Gamble Co.

Sanofi’s Chattem acquires Rolaids

Chattem Inc., the U.S. consumer health division of Sanofi, has completed the acquisition of the worldwide rights to the Rolaids antacid brand from the McNeil Consumer Healthcare Division of McNeil-PPC Inc.

Boehringer Ingelheim tool helps improve Rx adherence

Just as no two patients are alike, no single strategy should serve as the approach to improving medication adherence. That’s one of the principles behind the Patient Empowerment Program (PEP) that can be used by pharmacists to help improve compliance.

Watson cleared to release Lysteda generic

Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for tranexamic acid tablets, a medication for menstrual bleeding. The company said Thursday that it will immediately begin shipping the product, which is a generic equivalent to Ferring Pharmaceuticals’ Lysteda.